Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Neurotherapeutics (Editorial Board)



The Journal of the American Society for Experimental NeuroTherapeutics

Editor-in-Chief: Maral Mouradian

ISSN: 1933-7213 (print version)
ISSN: 1878-7479 (electronic version)

Journal no. 13311

$99.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 4 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy


M. Maral Mouradian, MD, Rutgers-Robert Wood Johnson Medical School

Associate Editors:

Gregory Bergey, MD, Johns Hopkins University School of Medicine

Rajiv R. Ratan, MD, PhD, Burke/Cornell Medical Research Institute

Editorial Board:

M. Flint Beal, MD, Weill Medical College of Cornell University

David Brooks, MD, Imperial College London

Amy Brooks-Kayal, MD, Children's Hospital Colorado, University of Colorado School of Medicine

Ashley Bush, MD, University of Melbourne

Rudolph J. Castellani, MD, University of Maryland School of Medicine

Jun Chen, MD, PhD, University of Pittsburgh School of Medicine

Marie-Francoise Chesselet, MD, PhD, University of California, Los Angeles

Merit Cudkowicz, MD, Massachusetts General Hospital

Steven T. DeKosky, MD, University of Virginia

Mahlon DeLong, MD, Emory University

W. Dalton Dietrich, PhD, University of Miami

Susan G. Dorsey, PhD RN, FAAN, University of Maryland Baltimore

Stewart A. Factor, DO, Emory University

Alan I. Faden MD, University of Maryland School of Medicine

Howard J. Federoff, MD, PhD, Georgetown University Medical Center

David J. Fink, MD, University of Michigan

Gary Fiskum, PhD, University of Maryland

Joel D. Greenspan, PhD, University of Maryland School of Dentistry

Robert C. Griggs, MD, University of Rochester

Edward D. Hall, PhD, University of Kentucky

Mark Hallett, MD, National Institute of Neurological Disorders and Stroke

Karl Herholz, MD, University of Manchester

Joseph Jankovic, MD, Baylor College of Medicine

Jeffrey H. Kordower, PhD, Rush University Medical Center

Gary Landreth, MD, Case Western Reserve University

Frank M. Longo, MD, PhD, Stanford University

Pedro Lowenstein, MD, PhD, University of Michigan Medical School  

Andres Lozano, MD, PhD, Toronto Western Research Institute

John W. Miller, MD, PhD, University of Washington

Hideki Mochizuki, MD, PhD, Osaka University

Peter F. Riederer, PhD, University of Wuerzburg

Michael A. Rogawski, MD, PhD, University of California, Davis

Jeffrey D. Rothstein, MD, PhD, Johns Hopkins School of Medicine

Richard A. Rudick, MD, The Cleveland Clinic Foundation

Christine Sang, MD, MPH, Brigham and Women’s Hospital

Steven Schachter, MD, Beth Israel Deaconess Medical Center

Magdy Selim, MD, PhD, Harvard Medical School

Jeremy M. Shefner, MD, PhD, SUNY Upstate Medical School

Solomon H. Snyder, MD, Johns Hopkins School of Medicine

Stephen M. Stahl, MD, PhD, University of California, San Diego

Thomas Sutula, MD, PhD, University of Wisconsin

Raymond A. Swanson, MD, UCSF School of Medicine

Robert Vink, MD, PhD, University of Adelaide

Michael Wang, MD, PhD, University of Michigan

Stephen G. Waxman, MD, PhD, Yale University School of Medicine

Patrick Y. Wen, MD, Brigham and Women’s Hospital

James Wheless, MD, The University of Tennessee Health Science Center

Prof. Dr. Heinz Wiendl, University of Muenster

V. Wee Yong, PhD, University of Calgary

Justin A. Zivin, MD, PhD, University of California, San Diego

For authors and editors

  • Journal Citation Reports®, Thomson Reuters
    2015 Impact Factor
  • 4.676
  • Aims and Scope

    Aims and Scope


    Neurotherapeutics® is the journal of the American Society for Experimental NeuroTherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders, written by international authorities. 

    The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.

    Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.

    Future Issue Themes:

    January 2017- Pharmacodynamic Markers in Early Diagnosis and Clinical Trial Endpoints in Neurology
    Guest Editor: Jeremy Shefner (University of Arizona), Marwan Sabbagh (University of Arizona)

    April 2017- Neuro-Oncology: New Concepts and Emerging Therapeutics
    Guest Editor: John Laterra (Johns Hopkins University), Burt Nabors (University of Alabama)

    July 2017- Emerging Therapies for Neuropsychiatric Disorders
    Guest Editor: Jay M. Baraban (Johns Hopkins University), Andrew Pieper (University of Iowa Carver School of Medicine)

    October 2017- Current and Future Therapies in Multiple Sclerosis
    Guest Editor: Jeffrey Cohen (Cleveland Clinic), Devon Conway (Cleveland Clinic), Le Hanh Hua (Cleveland Clinic )

    January 2018- Migraine Therapeutics: Current Practice, Recent Advances and Future Directions 
    Guest Editor: Peter Goadsby (King's College), Peter Holland (King's College)

    April 2018- The Bidirectional Flow Between the Microbiome and Brain in Neurologic Disease
    Guest Editor: Lloyd Kasper (Dartmouth), Javier Ochoa-Reparaz (Eastern Washington University) 

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors (pdf, 200 kB)
  • Conflict of Interest Form (pdf, 494 kB)

Alerts for this journal


Get the table of contents of every new issue published in Neurotherapeutics.